The Myeloma Risk Variant of TNFRSF13B Shows Reduced NF-κB Signalling Activity in HEK293 Cells

Richard Muyan Chen1, Jackie L Ludgate1, Robert J Weeks1

  • 1Department of Pathology and Molecular Medicine, University of Otago, Dunedin, New Zealand.

Insights

A genetic variant in TNFRSF13B, encoding TACI (transmembrane activator and CAML interactor), is linked to myeloma risk. The TACI P205L variant shows reduced NF-κB activity, suggesting an indirect role in disease development.

Area of Science:

  • Immunology
  • Genetics

Background:

  • A single nucleotide variant (rs34562254) in TNFRSF13B, encoding TACI, is associated with increased risk of myeloma and MGUS.
  • This variant results in a proline to leucine substitution at residue 251 (long isoform) or 205 (short isoform) of TACI.

Purpose of the Study:

  • To investigate the functional impact of the TACI P205L variant on NF-κB signaling.
  • To explore the potential indirect mechanism linking TACI P205L to myeloma risk.

Main Methods:

  • Utilized HEK293 cells for experiments.
  • Assessed NF-κB signaling using an NF-κB-luciferase reporter assay.
  • Quantified NF-κB p65 subcellular localization.

Main Results:

  • The TACI P205L variant exhibited significantly reduced NF-κB activity compared to the wild-type short isoform.
  • NF-κB p65 subcellular localization patterns may differ between variant and wild-type TACI.

Conclusions:

  • The reduced NF-κB activity associated with the TACI P205L variant suggests an indirect contribution to the increased risk of myeloma.
  • Further research is warranted to fully elucidate the role of TACI signaling in myeloma pathogenesis.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...